FDA Threatens Agency Action Against 23andMe Over Personal Genetic Testing
By EsqSocial Corporation 26/11/13
As reported in Fierce Medical Devices by Damian Garde, the FDA has issued a Warning Letter to personal genomics company 23andMe, demanding that the company stop selling its Personal Genomic Services (PGS) product without obtaining FDA approval. The...
By: McDonnell Boehnen Hulbert & Berghoff LLP